|
Volumn 41, Issue 16, 1998, Pages 2928-2931
|
Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, CP-336156, a diaryltetrahydronaphthalene [1]
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIESTROGEN;
CHOLESTEROL;
DIARYLTETRAHYDRONAPHTHALENE DERIVATIVE;
ESTRADIOL;
ESTROGEN DERIVATIVE;
ESTROGEN RECEPTOR;
ETHINYLESTRADIOL;
LASOFOXIFENE;
NAFOXIDINE;
NAPHTHALENE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTINEOPLASTIC ACTIVITY;
BONE ATROPHY;
BONE DENSITY;
BONE MINERAL;
BREAST CANCER;
CANCER CELL CULTURE;
CONTROLLED STUDY;
DRUG BIOAVAILABILITY;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
FEMALE;
HUMAN;
HYPERTROPHY;
LETTER;
MONKEY;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
OSTEOPOROSIS;
OVARIECTOMY;
RAT;
ADMINISTRATION, ORAL;
ANIMALS;
ANTILIPEMIC AGENTS;
BIOLOGICAL AVAILABILITY;
BONE DENSITY;
BREAST NEOPLASMS;
CELL DIVISION;
CHOLESTEROL;
ESTROGEN ANTAGONISTS;
ETHINYL ESTRADIOL;
FEMALE;
HUMANS;
NEOPLASMS, HORMONE-DEPENDENT;
ORGAN SIZE;
OVARIECTOMY;
PYRROLIDINES;
RATS;
RECEPTORS, ESTROGEN;
TETRAHYDRONAPHTHALENES;
TUMOR CELLS, CULTURED;
UTERUS;
|
EID: 0032581614
PISSN: 00222623
EISSN: None
Source Type: Journal
DOI: 10.1021/jm980048b Document Type: Letter |
Times cited : (131)
|
References (28)
|